Dosing errors did not have a major impact on outcome in the NINDS t-PA stroke study

Journal of Stroke and Cerebrovascular Diseases

Volumn 20, Issue 3, 2011, Pages 236-240

  Messé, Steven R ^a   Kasner, Scott E ^a   Cucchiara, Brett L ^a   Demchuk, Andrew ^b   Tanne, David ^c   Ouyang, Bichun ^d   Levine, Steven R ^e  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b FOOTHILLS HOSPITAL   (Canada)

^c SHEBA MEDICAL CENTER   (Israel)

^d RUSH UNIVERSITY MEDICAL CENTER   (United States)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

acute stroke; medical errors; Thrombolytic therapy; tissue plasminogen activator

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BODY WEIGHT; BRAIN HEMORRHAGE; COMPUTER ASSISTED TOMOGRAPHY; CONVALESCENCE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL ERROR; PRIORITY JOURNAL; STROKE; TREATMENT OUTCOME;

BODY WEIGHT; CEREBRAL HEMORRHAGE; DISABILITY EVALUATION; DRUG DOSAGE CALCULATIONS; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INFUSIONS, INTRAVENOUS; LOGISTIC MODELS; MALE; MEDICATION ERRORS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE; ODDS RATIO; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION; RISK ASSESSMENT; RISK FACTORS; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; UNITED STATES;

EID: 79955500302     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2010.01.002     Document Type: Article

References (17)

1. A. Valentin, M. Capuzzo, and B. Guidet Errors in administration of parenteral drugs in intensive care units: A multinational prospective study BMJ 338 2009 928 932
2. E.N. de Vries, M.A. Ramrattan, and S.M. Smorenburg The incidence and nature of in-hospital adverse events: A systematic review Qual Saf Health Care 17 2008 216 223
3. C.F. Richards, and C.P. Cannon Reducing medication errors: Potential benefits of bolus thrombolytic agents Acad Emerg Med 7 2000 1285 1289
4. R.H. Mehta, J.H. Alexander, and F. Van de Werf Relationship of incorrect dosing of fibrinolytic therapy and clinical outcomes JAMA 293 2005 1746 1750
5. S.R. Messé, D. Tanne, and A.M. Demchuk Dosing errors may impact the risk of rt-PA for stroke: The Multicenter rt-PA Acute Stroke Survey J Stroke Cerebrovasc Dis 13 2004 35 40 (Pubitemid 38419177)
6. The NINDS rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke N Engl J Med 333 1995 1581 1588
7. The NINDS rt-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke Stroke 28 1997 2109 2118
8. D. Tanne, S.E. Kasner, H. Mansbach for the rt-PA in Clinical Practice Study Group Intracerebral hemorrhage after intravenous rt-PA therapy for hyperacute ischemic stroke in clinical practice: Rate and predictors Cerebrovasc Dis 8 Suppl 4 1998 41
9. I. Dzialowski, J.H. Pexman, and P.A. Barber Asymptomatic hemorrhage after thrombolysis may not be benign: Prognosis by hemorrhage type in the Canadian Alteplase for Stroke Effectiveness Study registry Stroke 38 2007 75 79 (Pubitemid 46035609)
10. K. Kimura, Y. Iguchi, and K. Shibazaki Hemorrhagic transformation of ischemic brain tissue after t-PA thrombolysis as detected by MRI may be asymptomatic, but impair neurological recovery J Neurol Sci 272 2008 136 142
11. The NINDS t-PA Stroke Study Group. Generalized efficacy of t-PA for acute stroke: Subgroup analysis of the NINDS t-PA Stroke Trial Stroke 28 1997 2119 2125
12. J.R. Marler, B.C. Tilley, and M. Lu Early stroke treatment associated with better outcome: The NINDS rt-PA Stroke Study Neurology 55 2000 1649 1655
13. D. Tanne, S.E. Kasner, and A.M. Demchuk Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: The Multicenter rt-PA Stroke Survey Circulation 105 2002 1679 1685 (Pubitemid 34298612)
14. M. Lou, and M. Selim Does body weight influence the response to intravenous tissue plasminogen activator in stroke patients? Cerebrovasc Dis 27 2009 84 90
15. T.G. Brott, E.C. Haley, and D.E. Levy Urgent therapy for stroke, part I: Pilot study of tissue plasminogen activator administered within 90 minutes Stroke 23 1992 632 640
16. E.C. Haley Jr., D.E. Levy, and T.G. Brott Urgent therapy for stroke, part II: Pilot study of tissue plasminogen activator administered 91-180 minutes from onset Stroke 23 1992 641 645
17. E.C. Haley, T.G. Brott, and G.L. Sheppard Group ftTBS. Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke Stroke 24 1993 1000 1004 (Pubitemid 23201457)